Acquisition to advance company’s cell culture portfolio with internationally recognized pioneer in organoid development Burlington, Massachusetts, United States of America — MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced that the Life Science business of Merck KGaA, Darmstadt, Germany has signed a definitive agreement with the intention to acquire […]
Builds technology capabilities through vertical integration of proprietary bead technology and drives OEM business BILLERICA, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced the acquisition of EMISSION iNC. (“EMISSION”). Quanterix expects the transaction will close in January 2025. “As we expand our technology stack toward […]
First group of CSPs to offer MERSCOPE Platform Services and forthcoming MERFISH 2.0 Chemistry to global researchers CAMBRIDGE, Mass. ─ Vizgen, Inc., the life sciences company revolutionizing spatial genomics research and driving innovation in spatial multi-omics, today announced the official launch of its Certified Service Provider (CSP) program. The CSP initiative aims to empower researchers […]
PORTLAND, ME – Ovation.io, Inc. an organization dedicated to building best in class multi-omics datasets, today announced a collaboration with Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, that will work to accelerate advancements in precision medicine. The collaboration will address challenges in drug development by harnessing the power of genomic data to […]
FRAMINGHAM, Mass. — Complete Genomics, a San Jose, California based genomics tools manufacturer, today announced Framingham, Massachusetts based Eurofins Clinical Enterprise, LLC as the newest addition to its Sequencing Service Provider Program. Complete Genomics’ Service Provider Program connects its customers to a network of service providers, offering access to high-quality sequencing services using Complete Genomics DNBSEQ™ sequencing platforms. As part of the […]
BOTHELL, Wash. — BioLife Solutions, Inc. (Nasdaq: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces the appointment of Tony J. Hunt, Executive Chairman of Repligen Corporation (Nasdaq: RGEN) and a recognized leader in bioprocessing innovation, to its board of directors effective January 2, 2025. […]
bit.bio Raises $30 Million Led by M&G Investments to Focus on Tools for the Research, Drug Discovery and Cell Therapy Markets. Jonathan Milner Appointed Interim CEO; Mark Kotter Assumes Vice Chairman Role as Company Expands Board with Distinguished Biotech Leaders. Cambridge, UK – bit.bio, the global leader in cell programming technology, today announced the successful […]
Shimadzu Corporation has signed an investment contract with U-Medico Inc, (head office: Osaka prefecture; hereinafter U-Medico), a contract research organization (CRO). In accordance with this investment, from December 2024, Shimadzu has collaboratively developed a gene therapy pharmaceuticals manufacturing platform aimed at pharmaceutical companies, contract development and manufacturing organizations (CDMO), and educational & research institutions, and […]
HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostic products, today announced that NF Validation (AFNOR) has approved the extension of certification of the iQ-Check™ Listeria spp. and iQ-Check™ Listeria monocytogenes Kits for the real-time PCR detection of Listeria spp. and Listeria monocytogenes in food products for human consumption and in environmental samples […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
